Leadership
Floyd Taub, MD
Dr. Taub is a physician-scientist, entrepreneur who revolutionized cancer diagnostics. He founded Digene, the company that made the first non-radioactive DNA test for any cancer detection/screening. That test detected HPV. HPV testing has prevented more cancers than any other screening method, but it is focused on cervical cancer. Qiagen subsequently acquired Digene for $1.6 billion.
aiGENE is expanding on DNA testing by using urine as a source of DNA to potentially detect most all cancers and certain other diseases. AACR postersRead More
Founder of Dovetail Technologies, LifeTime Pharmaceuticals and FindCure.Org; organizations that coordinated to take the first drug that modulated immune checkpoint molecules into clinical trials.
Head biomedical scientist/pathologist at OTraces, Veramarx, ClearCreek Partners, AccuBiome and AxImmune.
CEO of CytoCore, CYOE
National Institutes of Health (NIH) including heading a pathology unit.
George Washington University
University of Colorado Medical Center
Northwestern University (M.D)
50+ scientific publications & presentations
12+ patent families
Advisors
Stan Lapidus
Founder and CEO of Cytyc and Exact Sciences. These cancer screening companies sold for $6.2 billion and $23 billion respectively. They both created revolutionary products, Cytyc automated and greatly enhanced PAP slide preparation via the "ThinPrep”; Exact created the first DNA cancer screening test for colon cancer (Cologuard).
Read More
2026 honoree of the American Cancer Society Denver Champions of Hope Gala
Forbes recognized Stan as one of America’s Top 250 Greatest Innovators, honoring the life-saving impact of Cologuard.
37 US patents
Harvey Buck
Developed diagnostic tests for Roche, Boehringer Mannheim and Miles Laboratories
Read More
Over 50 patents
Werner Kuhr
Associate Vice President for Innovation and Entrepreneurship at Texas Tech University. He oversees research commercialization, the Innovation Hub, and entrepreneurship programs serving Texas Tech and Texas Tech University Health Sciences Center.
Read More
Director of the Center for Entrepreneurship, Colorado School of Mines
Founding director of the Stevens Venture Center
Co-founder and VP of Research at ZettaCore
Chemistry Professor at UC Riverside.
Helped form five technology startups, including companies in protein diagnostics and genomics. His university biography reports approximately $95 million raised in venture capital and over $400 million returned to investors and shareholders.
David K Stone
Brings a unique combination of biotech financial analysis, venture investing, operating/CFO, public and private company experience and scientific training, as well as a Harvard MBA, to aiGENE
Read More
Flagship Ventures (now Flagship Pioneering) — Managing Director & Partner (2000–2006)
Cowen & Company (NASDAQ: COWN) — Managing Director; led biotechnology equity research (1989–1999)
Genetics Institute (NASDAQ: GENI) — Project management and corporate communications
Liberty Tree Advisors — Founder & Managing Director
Gen9 — Chief Financial Officer; synthetic-DNA company
Oscient Pharmaceuticals (NASDAQ: OSCI) — Chairman
MELA Sciences (NASDAQ: MELA; now STRATA Skin Sciences, NASDAQ: SSKN) — Lead Independent Director Fintel
Seahorse Bioscience — Board Director; acquired by Agilent (NYSE: A)
Morphotek — Board Director; acquired by Eisai (TSE: 4523)
Hypnion — Board Director; acquired by Eli Lilly (NYSE: LLY)
PAKA Pulmonary Pharmaceuticals — Board Director
Colorado State University — B.S., Microbiology
Harvard Business School — MBA